259 related articles for article (PubMed ID: 36310035)
1. Transport of the Proinflammatory Chemokines C-C Motif Chemokine Ligand 2 (MCP-1) and C-C Motif Chemokine Ligand 5 (RANTES) across the Intact Mouse Blood-Brain Barrier Is Inhibited by Heparin and Eprodisate and Increased with Systemic Inflammation.
Quaranta DV; Weaver RR; Baumann KK; Fujimoto T; Williams LM; Kim HC; Logsdon AF; Omer M; Reed MJ; Banks WA; Erickson MA
J Pharmacol Exp Ther; 2023 Jan; 384(1):205-223. PubMed ID: 36310035
[TBL] [Abstract][Full Text] [Related]
2. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.
Raghu H; Lepus CM; Wang Q; Wong HH; Lingampalli N; Oliviero F; Punzi L; Giori NJ; Goodman SB; Chu CR; Sokolove JB; Robinson WH
Ann Rheum Dis; 2017 May; 76(5):914-922. PubMed ID: 27965260
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of beta-chemokines MCP-1 and RANTES and their receptors CCR1, CCR2, CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts.
Rüster M; Sperschneider H; Fünfstück R; Stein G; Gröne HJ
Clin Nephrol; 2004 Jan; 61(1):30-9. PubMed ID: 14964455
[TBL] [Abstract][Full Text] [Related]
4. C-C motif chemokine ligand (CCL) production in equine peripheral blood mononuclear cells identified by newly generated monoclonal antibodies.
Schnabel CL; Wemette M; Babasyan S; Freer H; Baldwin C; Wagner B
Vet Immunol Immunopathol; 2018 Oct; 204():28-39. PubMed ID: 30596378
[TBL] [Abstract][Full Text] [Related]
5. Production of proinflammatory cytokines and chemokines during neuroinflammation: novel roles for estrogen receptors alpha and beta.
Brown CM; Mulcahey TA; Filipek NC; Wise PM
Endocrinology; 2010 Oct; 151(10):4916-25. PubMed ID: 20685874
[TBL] [Abstract][Full Text] [Related]
6. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS.
Eugenin EA; Osiecki K; Lopez L; Goldstein H; Calderon TM; Berman JW
J Neurosci; 2006 Jan; 26(4):1098-106. PubMed ID: 16436595
[TBL] [Abstract][Full Text] [Related]
7. Regulation of inflammatory chemokine receptors on blood T cells associated to the circulating versus liver chemokines in dengue fever.
de-Oliveira-Pinto LM; Marinho CF; Povoa TF; de Azeredo EL; de Souza LA; Barbosa LD; Motta-Castro AR; Alves AM; Ávila CA; de Souza LJ; da Cunha RV; Damasco PV; Paes MV; Kubelka CF
PLoS One; 2012; 7(7):e38527. PubMed ID: 22815692
[TBL] [Abstract][Full Text] [Related]
8. Expression of the chemokines MCP-1/CCL2 and RANTES/CCL5 is differentially regulated by infiltrating inflammatory cells.
Haberstroh U; Pocock J; Gómez-Guerrero C; Helmchen U; Hamann A; Gutierrez-Ramos JC; Stahl RA; Thaiss F
Kidney Int; 2002 Oct; 62(4):1264-76. PubMed ID: 12234296
[TBL] [Abstract][Full Text] [Related]
9. The enhancement of CCL2 and CCL5 by human bone marrow-derived mesenchymal stem/stromal cells might contribute to inflammatory suppression and axonal extension after spinal cord injury.
Yagura K; Ohtaki H; Tsumuraya T; Sato A; Miyamoto K; Kawada N; Suzuki K; Nakamura M; Kanzaki K; Dohi K; Izumizaki M; Hiraizumi Y; Honda K
PLoS One; 2020; 15(3):e0230080. PubMed ID: 32155215
[TBL] [Abstract][Full Text] [Related]
10. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS.
Babcock AA; Kuziel WA; Rivest S; Owens T
J Neurosci; 2003 Aug; 23(21):7922-30. PubMed ID: 12944523
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal chemokine profile expression in a blood-brain barrier model from Alzheimer transgenic versus wild-type mice.
Vérité J; Janet T; Chassaing D; Fauconneau B; Rabeony H; Page G
J Neuroinflammation; 2018 Jun; 15(1):182. PubMed ID: 29898739
[TBL] [Abstract][Full Text] [Related]
12. Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease.
Reale M; Iarlori C; Feliciani C; Gambi D
J Alzheimers Dis; 2008 Jun; 14(2):147-59. PubMed ID: 18560127
[TBL] [Abstract][Full Text] [Related]
13. Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice.
Braunersreuther V; Pellieux C; Pelli G; Burger F; Steffens S; Montessuit C; Weber C; Proudfoot A; Mach F; Arnaud C
J Mol Cell Cardiol; 2010 Apr; 48(4):789-98. PubMed ID: 19665464
[TBL] [Abstract][Full Text] [Related]
14. Chemokine MCP1/CCL2 and RANTES/CCL5 gene polymorphisms influence Henoch-Schönlein purpura susceptibility and severity.
Yu HH; Liu PH; Yang YH; Lee JH; Wang LC; Chen WJ; Chiang BL
J Formos Med Assoc; 2015 Apr; 114(4):347-52. PubMed ID: 25839768
[TBL] [Abstract][Full Text] [Related]
15. Arrestin Recruitment to C-C Chemokine Receptor 5: Potent C-C Chemokine Ligand 5 Analogs Reveal Differences in Dependence on Receptor Phosphorylation and Isoform-Specific Recruitment Bias.
Martins E; Brodier H; Rossitto-Borlat I; Ilgaz I; Villard M; Hartley O
Mol Pharmacol; 2020 Nov; 98(5):599-611. PubMed ID: 32943494
[TBL] [Abstract][Full Text] [Related]
16. Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes.
Vielhauer V; Anders HJ; Mack M; Cihak J; Strutz F; Stangassinger M; Luckow B; Gröne HJ; Schlöndorff D
J Am Soc Nephrol; 2001 Jun; 12(6):1173-1187. PubMed ID: 11373340
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication by chemokines.
Gyoneva S; Ransohoff RM
Trends Pharmacol Sci; 2015 Jul; 36(7):471-80. PubMed ID: 25979813
[TBL] [Abstract][Full Text] [Related]
18. High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo.
Bursill CA; Castro ML; Beattie DT; Nakhla S; van der Vorst E; Heather AK; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1773-8. PubMed ID: 20702809
[TBL] [Abstract][Full Text] [Related]
19. Annulus fibrosus cells express and utilize C-C chemokine receptor 5 (CCR5) for migration.
Liu W; Liu D; Zheng J; Shi P; Chou PH; Oh C; Chen D; An HS; Chee A
Spine J; 2017 May; 17(5):720-726. PubMed ID: 28108404
[TBL] [Abstract][Full Text] [Related]
20. CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment.
Bandinelli F; Del Rosso A; Gabrielli A; Giacomelli R; Bartoli F; Guiducci S; Matucci Cerinic M
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S44-9. PubMed ID: 22691208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
